Nova Biomedical is a global leader in healthcare diagnostics, bioprocessing technologies that support drug development, food and beverage analytical testing, and solutions for veterinary medicine. We are committed to advancing patient care and accelerating scientific discovery through the development of cutting-edge instrumentation and innovation. As the largest privately held in vitro diagnostics company in the United States and one of the fastest-growing worldwide, Nova serves customers in more than 100 countries. Our significant annual reinvestment in R&D fuels a robust pipeline of breakthrough technologies.